Q2 2019 Otsuka Holdings Co Ltd Earnings Presentation Transcript
Let me explain our consolidated financial results FY 2019 for second quarter. Please look at page 3. I will cover these 4 topics today. First, let me give you an outline of consolidated financial results of the second quarter of FY 2019. Sales of 4 global products of the pharmaceutical segment increased by 36.6% year-on-year and exceeded FY 2019 forecast with its progress rate at 105.6%, significantly contributing to total revenue growth. Business profit before R&D expenses grew by 25.9% year-on-year, also exceeding FY 2019 forecast with progress rate at 108.6%.
In addition, R&D investment towards sustainable growth increased by 14.6% year-on-year, with clinical trials progressing as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
